AZD-4877

DB11671InvestigationalSmall molecule

AZD4877 has been used in trials studying the treatment of NHL, Tumors, Cancer, Lymphoma, and Neoplasms, among others.

Mechanism: Pharmacologically active on Kinesin-like protein KIF11
Curator reviewed
Formula / weight: C₂₈H₃₃N₅O₂S · 503.67 g/mol (avg)
Code names: AZD-4877

Resolves to

Compound

Structure

InChIKeySMFXSYMLJDHGIE-UHFFFAOYSA-NSMILESCC(C)C(N(CCCN)C(=O)C1=CC=C(C)C=C1)C1=NC2=C(C(C)=NS2)C(=O)N1CC1=CC=CC=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with AZD-4877, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.